investor compensation

139 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

ODDITY Tech Faces Securities Lawsuit Over Hidden Algorithm Changes

Rosen Law Firm files class action against ODDITY Tech (NASDAQ: ODD) for allegedly concealing algorithm changes that boosted customer acquisition costs between February 2025-2026.
ODDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Plug Power Faces Securities Class Action Over DOE Loan Claims

Rosen Law Firm urges $PLUG investors to join class action lawsuit by April 3, 2026 deadline alleging false statements about DOE funding.
PLUGsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Beyond Meat Faces Securities Lawsuit Over Asset Impairment Claims

Securities lawsuit filed against $BYND alleges false statements on asset values. Investors have until March 24 deadline to join class action.
BYNDsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

REGENXBIO Faces Securities Class Action Over Gene Therapy Misstatements

Securities lawsuit filed against $RGNX for allegedly misleading investors about RGX-111 gene therapy efficacy and safety. Lead plaintiff deadline April 14, 2026.
RGNXsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Soleno Therapeutics Faces Class Action Over Undisclosed Safety Risks in DCCR Drug

Rosen Law Firm files securities class action against $SLNO for alleged misstatements regarding safety concerns with DCCR drug candidate for Prader-Willi syndrome treatment.
SLNOsecurities class actionlead plaintiff
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

America's Car-Mart Stock Plunges 18% After Surprise Loss; Securities Probe Launched

America's Car-Mart stock plunges 18% after reporting unexpected quarterly loss; securities investigation launched over alleged misleading disclosures.
CRMTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Navan Hit With Securities Suit Over IPO Disclosure Claims

Class action lawsuit filed against $NAAM alleges October 2025 IPO prospectus contained false statements about sales and marketing expenses. Lead plaintiff deadline: April 24, 2026.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Eos Energy Investors Face May 2026 Deadline in Securities Class Action

Rosen Law Firm pursues class action against Eos Energy Enterprises for alleged false statements about operations and guidance. Investors must act by May 5, 2026 deadline.
SMREOSENKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Class Action Lawsuits Target Nektar, Enphase Over Alleged False Statements

Rosen Law Firm files securities class actions against Nektar Therapeutics, Enphase Energy, and Aquestive Therapeutics. Investors have until May 5, 2026 to join.
ENPHAQSTNKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Enphase Energy Faces Securities Lawsuit Over Inventory, Credit Termination Claims

Rosen Law Firm filed securities class action against Enphase Energy ($ENPH) alleging false statements on inventory and renewable energy credits. Deadline April 20, 2026.
ENPHAQSTNKTRsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Class Action Lawsuit Filed Against Aquestive Therapeutics Over Alleged Securities Violations

Rosen Law Firm filed class action against Aquestive Therapeutics alleging false statements about product development and regulatory matters. Eligible investors should act before deadline.
ENPHAQSTNKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

REGENXBIO Hit With Securities Lawsuit Over Gene Therapy Claims

REGENXBIO faces securities lawsuit over alleged misleading RGX-111 gene therapy statements. Lead plaintiff deadline is April 14, 2026.
RGNXsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Bath & Body Works Faces Securities Lawsuit Over Failed Growth Strategy

Rosen Law Firm urges $BBWI investors to join class action by March 16, 2026 deadline, alleging materially false statements about business strategy and unmet financial guidance.
BBWIsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Snowflake Faces Securities Class Action Over Undisclosed Product Impact

Rosen Law Firm alerts $SNOW investors of April 27, 2026 deadline in class action alleging undisclosed negative impacts from product efficiency gains.
SNOWsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Suit Against Richtech Robotics Over Alleged Microsoft Partnership Fraud

Rosen Law Firm sued Richtech Robotics for allegedly misrepresenting a Microsoft partnership. Investors must file claims by April 3, 2026.
CORTRRFBRTFBRTpEsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Files Securities Class Action Against Franklin BSP Realty Trust

Rosen Law Firm files securities class action against Franklin BSP Realty Trust alleging false statements. Investors must act before lead plaintiff deadline.
CORTRRFBRTFBRTpEsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Firm Urges Endeavor Investors to Act Before March 18 Deadline in Securities Lawsuit

Rosen Law Firm urges Endeavor Group Holdings investors to secure counsel before March 18 deadline in securities class action over alleged false SEC filings.
PLUGDRVNsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Paysafe Faces Securities Class Action Over Undisclosed Business Risks

Rosen Law Firm reminds $PSFE investors of April 7, 2026 deadline in securities lawsuit alleging false statements on ecommerce exposure and credit reserves.
PSFEsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Class Action Filed Against Aquestive Therapeutics Over Anaphylm Drug Application Disclosures

Rosen Law Firm files securities class action against $AQST over alleged misleading statements regarding its Anaphylm drug application between June 2025 and January 2026.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Boston Scientific Faces Securities Class Action Over False Electrophysiology Claims

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability and concealed adverse facts.
BSXEOSESLNOsecurities fraudclass action lawsuit